Nuclear Smad7 overexpressed in mesenchymal cells acts as a transcriptional corepressor by interacting with HDAC-1 and E2F to regulate cell cycle

Biology Open

Volumn 1, Issue 3, 2012, Pages 247-260

  Emori, Takashi ^a,b   Kitamura, Koki ^a,c   Okazaki, Kenji ^a,d  

^a BIOMOL ENG RESEARCH INSTITUTE   (Japan)

^b ASTELLAS PHARMA INC   (Japan)

^c Astellas Research Institute of America LLC   (United States)

^d KYOTO UNIVERSITY   (Japan)

Author keywords

Cell cycle; E2F; Histone deacetylase; Smad; Transcriptional corepressor

Indexed keywords

EID: 84964681390     PISSN: None     EISSN: 20466390     Source Type: Journal    
DOI: 10.1242/bio.2012463     Document Type: Article

References (102)

1. Afrakhte, M., Moren, A., Jossan, S., Itoh, S., Sampath, K., Westermark, B., Heldin, C. H., Heldin, N. E. and ten Dijke, P. (1998). Induction of inhibitory Smad6 and Smad7 mRNA by TGF-beta family members. Biochem. Biophys. Res. Commun. 249, 505-511.
2. Allfrey, V. G., Faulkner, R. and Mirsky, A. E. (1964). Acetylation and methylation of histones and their possible role in the regulation of RNA synthesis. Proc. Natl. Acad. Sci. USA 51, 786-794.
3. Aota, S., Nakajima, N., Sakamoto, R., Watanabe, S., Ibaraki, N. and Okazaki, K. (2003). Pax6 autoregulation mediated by direct interaction of Pax6 protein with the head surface ectoderm-specific enhancer of the mouse Pax6 gene. Dev. Biol. 257, 1-13.
4. Bai, S. and Cao, X. (2002). A nuclear antagonistic mechanism of inhibitory Smads in transforming growth factor-beta signaling. J. Biol. Chem. 277, 4176-4182.
5. Bai, S., Shi, X., Yang, X. and Cao, X. (2000). Smad6 as a transcriptional corepressor. J. Biol. Chem. 275, 8267-8270.
6. Baltus, G. A., Kowalski, M. P., Zhai, H., Tutter, A. V., Quinn, D., Wall, D. and Kadam, S. (2009). Acetylation of sox2 induces its nuclear export in embryonic stem cells. Stem Cells 27, 2175-2184.
7. Basile, J. R., Eichten, A., Zacny, V. and Munger, K. (2003). NF-kappaB-mediated induction of p21(Cip1/Waf1) by tumor necrosis factor alpha induces growth arrest and cytoprotection in normal human keratinocytes. Mol. Cancer Res. 1, 262-270.
8. Beijersbergen, R. L., Carlee, L., Kerkhoven, R. M. and Bernards, R. (1995). Regulation of the retinoblastoma protein-related p107 by G1 cyclin complexes. Genes Dev. 9, 1340-1353.
9. Bhushan, A., Chen, Y. and Vale, W. (1998). Smad7 inhibits mesoderm formation and promotes neural cell fate in Xenopus embryos. Dev. Biol. 200, 260-268.
10. Bitzer, M., von Gersdorff, G., Liang, D., Dominguez-Rosales, A., Beg, A. A., Rojkind, M. and Bottinger, E. P. (2000). A mechanism of suppression of TGF-beta/SMAD signaling by NF-kappa B/RelA. Genes Dev. 14, 187-197.
11. Blake, M. C. and Azizkhan, J. C. (1989). Transcription factor E2F is required for efficient expression of the hamster dihydrofolate reductase gene in vitro and in vivo. Mol. Cell. Biol. 9, 4994-5002.
12. Bolden, J. E., Peart, M. J. and Johnstone, R. W. (2006). Anticancer activities of histone deacetylase inhibitors. Nat. Rev. Drug Discov. 5, 769-784.
13. Brehm, A., Miska, E. A., McCance, D. J., Reid, J. L., Bannister, A. J. and Kouzarides, T. (1998). Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391, 597-601.
14. Chen, C. R., Kang, Y., Siegel, P. M. and Massague, J. (2002). E2F4/5 and p107 as Smad cofactors linking the TGFbeta receptor to c-myc repression. Cell 110, 19-32.
15. Chen, X., Weisberg, E., Fridmacher, V., Watanabe, M., Naco, G. and Whitman, M. (1997). Smad4 and FAST-1 in the assembly of activin-responsive factor. Nature 389, 85-89.
16. Choy, L., Skillington, J. and Derynck, R. (2000). Roles of autocrine TGF-beta receptor and Smad signaling in adipocyte differentiation. J. Cell Biol. 149, 667-682.
17. Classon, M. and Dyson, N. (2001). p107 and p130: versatile proteins with interesting pockets. Exp. Cell Res. 264, 135-147.
18. Cress, W. D. and Seto, E. (2000). Histone deacetylases, transcriptional control, and cancer. J. Cell. Physiol. 184, 1-16.
19. de Ruijter, A. J., van Gennip, A. H., Caron, H. N., Kemp, S. and van Kuilenburg, A. B. (2003). Histone deacetylases (HDACs): characterization of the classical HDAC family. Biochem. J. 370, 737-749.
20. DeGregori, J., Leone, G., Miron, A., Jakoi, L. and Nevins, J. R. (1997). Distinct roles for E2F proteins in cell growth control and apoptosis. Proc. Natl. Acad. Sci. USA 94, 7245-7250.
21. Dyson, N. (1998). The regulation of E2F by pRB-family proteins. Genes Dev. 12, 2245-2262.
22. Fagan, R., Flint, K. J. and Jones, N. (1994). Phosphorylation of E2F-1 modulates its interaction with the retinoblastoma gene product and the adenoviral E4 19 kDa protein. Cell 78, 799-811.
23. Fajas, L., Egler, V., Reiter, R., Hansen, J., Kristiansen, K., Debril, M. B., Miard, S. and Auwerx, J. (2002). The retinoblastoma-histone deacetylase 3 complex inhibits PPARgamma and adipocyte differentiation. Dev. Cell 3, 903-910.
24. Flaus, A. and Owen-Hughes, T. (2001). Mechanisms for ATP-dependent chromatin remodelling. Curr. Opin. Genet. Dev. 11, 148-154.
25. Freiman, R. N. and Tjian, R. (2003). Regulating the regulators: lysine modifications make their mark. Cell 112, 11-17.
26. Frolov, M. V. and Dyson, N. J. (2004). Molecular mechanisms of E2F-dependent activation and pRB-mediated repression. J. Cell Sci. 117, 2173-2181.
27. Fry, C. J., Slansky, J. E. and Farnham, P. J. (1997). Position-dependent transcriptional regulation of the murine dihydrofolate reductase promoter by the E2F transactivation domain. Mol. Cell. Biol. 17, 1966-1976.
28. Fry, C. J., Pearson, A., Malinowski, E., Bartley, S. M., Greenblatt, J. and Farnham, P. J. (1999). Activation of the murine dihydrofolate reductase promoter by E2F1. A requirement for CBP recruitment. J. Biol. Chem. 274, 15883-15891.
29. Grana, X., Garriga, J. and Mayol, X. (1998). Role of the retinoblastoma protein family, pRB, p107 and p130 in the negative control of cell growth. Oncogene 17, 3365-3383.
30. Gronroos, E., Hellman, U., Heldin, C. H. and Ericsson, J. (2002). Control of Smad7 stability by competition between acetylation and ubiquitination. Mol. Cell 10, 483-493.
31. Hassig, C. A., Tong, J. K., Fleischer, T. C., Owa, T., Grable, P. G., Ayer, D. E. and Schreiber, S. L. (1998). A role for histone deacetylase activity in HDAC1-mediated transcriptional repression. Proc. Natl. Acad. Sci. USA 95, 3519-3524.
32. Hata, A., Lagna, G., Massague, J. and Hemmati-Brivanlou, A. (1998). Smad6 inhibits BMP/Smad1 signaling by specifically competing with the Smad4 tumor suppressor. Genes Dev. 12, 186-197.
33. Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y. Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Jr, Wrana, J. L. et al. (1997). The MADrelated protein Smad7 associates with the TGFbeta receptor and functions as an antagonist of TGFbeta signaling. Cell 89, 1165-1173.
34. Heikkinen, P. T., Nummela, M., Jokilehto, T., Grenman, R., Kahari, V. M. and Jaakkola, P. M. (2010). Hypoxic conversion of SMAD7 function from an inhibitor into a promoter of cell invasion. Cancer Res. 70, 5984-5993.
35. Heldin, C. H., Miyazono, K. and ten Dijke, P. (1997). TGF-beta signalling from cell membrane to nucleus through SMAD proteins. Nature 390, 465-471.
36. Heldin, C. H., Landstrom, M. and Moustakas, A. (2009). Mechanism of TGF-beta signaling to growth arrest, apoptosis, and epithelial-mesenchymal transition. Curr. Opin. Cell Biol. 21, 166-176.
37. Helin, K. (1998). Regulation of cell proliferation by the E2F transcription factors. Curr. Opin. Genet. Dev. 8, 28-35.
38. Hogan, B. L. (1996). Bone morphogenetic proteins in development. Curr. Opin. Genet. Dev. 6, 432-438.
39. Humphrey, G. W., Wang, Y. H., Hirai, T., Padmanabhan, R., Panchision, D. M., Newell, L. F., McKay, R. D. and Howard, B. H. (2008). Complementary roles for histone deacetylases 1, 2, and 3 in differentiation of pluripotent stem cells. Differentiation 76, 348-356.
40. Ichijo, T., Voutetakis, A., Cotrim, A. P., Bhattachryya, N., Fujii, M., Chrousos, G. P. and Kino, T. (2005). The Smad6-histone deacetylase 3 complex silences the transcriptional activity of the glucocorticoid receptor: potential clinical implications. J. Biol. Chem. 280, 42,067-42,077.
41. Imamura, T., Takase, M., Nishihara, A., Oeda, E., Hanai, J., Kawabata, M. and Miyazono, K. (1997). Smad6 inhibits signalling by the TGF-beta superfamily. Nature 389, 622-626.
42. Inman, G. J., Nicolas, F. J. and Hill, C. S. (2002). Nucleocytoplasmic shuttling of Smads 2, 3, and 4 permits sensing of TGF-beta receptor activity. Mol. Cell 10, 283-294.
43. Ito, A., Kawaguchi, Y., Lai, C. H., Kovacs, J. J., Higashimoto, Y., Appella, E. and Yao, T. P. (2002). MDM2-HDAC1-mediated deacetylation of p53 is required for its degradation. EMBO J. 21, 6236-6245.
44. Itoh, S., Landstrom, M., Hermansson, A., Itoh, F., Heldin, C. H., Heldin, N. E. and ten Dijke, P. (1998). Transforming growth factor beta1 induces nuclear export of inhibitory Smad7. J. Biol. Chem. 273, 29,195-29,201.
45. Jeoung, D. I., Tang, B. and Sonenberg, M. (1995). Effects of tumor necrosis factoralpha on antimitogenicity and cell cycle-related proteins in MCF-7 cells. J. Biol. Chem. 270, 18367-18373.
46. Jin, Y. H., Jeon, E. J., Li, Q. L., Lee, Y. H., Choi, J. K., Kim, W. J., Lee, K. Y. and Bae, S. C. (2004). Transforming growth factor-beta stimulates p300-dependent RUNX3 acetylation, which inhibits ubiquitination-mediated degradation. J. Biol. Chem. 279, 29409-29417.
47. Johnstone, R. W. (2002). Histone-deacetylase inhibitors: novel drugs for the treatment of cancer. Nat. Rev. Drug Discov. 1, 287-299.
48. Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H. and Wrana, J. L. (2000). Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365-1375.
49. Khochbin, S., Verdel, A., Lemercier, C. and Seigneurin-Berny, D. (2001). Functional significance of histone deacetylase diversity. Curr. Opin. Genet. Dev. 11, 162-166.
50. Kitamura, K., Aota, S., Sakamoto, R., Yoshikawa, S. I. and Okazaki, K. (2000). Smad7 selectively interferes with different pathways of activin signaling and inhibits erythroid leukemia cell differentiation. Blood 95, 3371-3379.
51. Kitamura, K., Aota, S., Sakamoto, R., Emori, T. and Okazaki, K. (2005). Smad7 induces G0/G1 cell cycle arrest in mesenchymal cells by inhibiting the expression of G1 cyclins. Dev. Growth Differ. 47, 537-552.
52. Kollias, H. D., Perry, R. L., Miyake, T., Aziz, A. and McDermott, J. C. (2006). Smad7 promotes and enhances skeletal muscle differentiation. Mol. Cell. Biol. 26, 6248-6260.
53. Kouzarides, T. (1999). Histone acetylases and deacetylases in cell proliferation. Curr. Opin. Genet. Dev. 9, 40-48.
54. Kouzarides, T. (2000). Acetylation: a regulatory modification to rival phosphorylation? EMBO J. 19, 1176-1179.
55. Lam, E. W. and La Thangue, N. B. (1994). DP and E2F proteins: coordinating transcription with cell cycle progression. Curr. Opin. Cell Biol. 6, 859-866.
56. Lee, K. K. and Workman, J. L. (2007). Histone acetyltransferase complexes: one size doesn't fit all. Nat. Rev. Mol. Cell Biol. 8, 284-295.
57. Luo, R. X., Postigo, A. A. and Dean, D. C. (1998). Rb interacts with histone deacetylase to repress transcription. Cell 92, 463-473.
58. Magnaghi-Jaulin, L., Groisman, R., Naguibneva, I., Robin, P., Lorain, S., Le Villain, J. P., Troalen, F., Trouche, D. and Harel-Bellan, A. (1998). Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391, 601-605.
59. Mal, A., Sturniolo, M., Schiltz, R. L., Ghosh, M. K. and Harter, M. L. (2001). A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 20, 1739-1753.
60. Marmorstein, R. and Roth, S. Y. (2001). Histone acetyltransferases: function, structure, and catalysis. Curr. Opin. Genet. Dev. 11, 155-161.
61. Massague, J. (1998). TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791.
62. Massague, J. and Wotton, D. (2000). Transcriptional control by the TGF-beta/Smad signaling system. EMBO J. 19, 1745-1754.
63. Miyake, T., Alli, N. S. and McDermott, J. C. (2010). Nuclear function of Smad7 promotes myogenesis. Mol. Cell. Biol. 30, 722-735.
64. Moustakas, A., Souchelnytskyi, S. and Heldin, C. H. (2001). Smad regulation in TGFbeta signal transduction. J. Cell Sci. 114, 4359-4369.
65. Mulligan, G. and Jacks, T. (1998). The retinoblastoma gene family: cousins with overlapping interests. Trends Genet. 14, 223-229.
66. Nagy, L., Kao, H. Y., Chakravarti, D., Lin, R. J., Hassig, C. A., Ayer, D. E., Schreiber, S. L. and Evans, R. M. (1997). Nuclear receptor repression mediated by a complex containing SMRT, mSin3A, and histone deacetylase. Cell 89, 373-380.
67. Nakao, A., Afrakhte, M., Moren, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N. E., Heldin, C. H. et al. (1997). Identification of Smad7, a TGFbeta-inducible antagonist of TGF-beta signalling. Nature 389, 631-635.
68. Nakayama, T., Gardner, H., Berg, L. K. and Christian, J. L. (1998). Smad6 functions as an intracellular antagonist of some TGF-beta family members during Xenopus embryogenesis. Genes Cells 3, 387-394.
69. Nevins, J. R. (1998). Toward an understanding of the functional complexity of the E2F and retinoblastoma families. Cell Growth Differ. 9, 585-593.
70. Okazaki, K. and Sagata, N. (1995). The Mos/MAP kinase pathway stabilizes c-Fos by phosphorylation and augments its transforming activity in NIH 3T3 cells. EMBO J. 14, 5048-5059.
71. Phillips, D. M. (1968). N-Terminal acetyl-peptides from two calf thymus histones. Biochem. J. 107, 135-138.
72. Polager, S. and Ginsberg, D. (2008). E2F-at the crossroads of life and death. Trends Cell Biol. 18, 528-535.
73. Polyak, K., Kato, J. Y., Solomon, M. J., Sherr, C. J., Massague, J., Roberts, J. M. and Koff, A. (1994). p27Kip1, a cyclin-Cdk inhibitor, links transforming growth factor-beta and contact inhibition to cell cycle arrest. Genes Dev. 8, 9-22.
74. Qin, B. Y., Chacko, B. M., Lam, S. S., de Caestecker, M. P., Correia, J. J. and Lin, K. (2001). Structural basis of Smad1 activation by receptor kinase phosphorylation. Mol. Cell 8, 1303-1312.
75. Quan, T., He, T., Voorhees, J. J. and Fisher, G. J. (2001). Ultraviolet irradiation blocks cellular responses to transforming growth factor-beta by down-regulating its type-II receptor and inducing Smad7. J. Biol. Chem. 276, 26349-26356.
76. Raftery, L. A. and Sutherland, D. J. (1999). TGF-beta family signal transduction in Drosophila development: from Mad to Smads. Dev. Biol. 210, 251-268.
77. Sambucetti, L. C., Fischer, D. D., Zabludoff, S., Kwon, P. O., Chamberlin, H., Trogani, N., Xu, H. and Cohen, D. (1999). Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects. J. Biol. Chem. 274, 34940-34947.
78. Seoane, J., Pouponnot, C., Staller, P., Schader, M., Eilers, M. and Massague, J. (2001). TGFbeta influences Myc, Miz-1 and Smad to control the CDK inhibitor p15INK4b. Nat. Cell Biol. 3, 400-408.
79. Simonsson, M., Heldin, C. H., Ericsson, J. and Gronroos, E. (2005). The balance between acetylation and deacetylation controls Smad7 stability. J. Biol. Chem. 280, 21,797-21,803.
80. Spange, S., Wagner, T., Heinzel, T. and Kramer, O. H. (2009). Acetylation of nonhistone proteins modulates cellular signalling at multiple levels. Int. J. Biochem. Cell Biol. 41, 185-198.
81. Sporn, M. B. and Roberts, A. B. (1992). Transforming growth factor-beta: recent progress and new challenges. J. Cell Biol. 119, 1017-1021.
82. Subramaniam, P. S., Cruz, P. E., Hobeika, A. C. and Johnson, H. M. (1998). Type I interferon induction of the Cdk-inhibitor p21WAF1 is accompanied by ordered G1 arrest, differentiation and apoptosis of the Daudi B-cell line. Oncogene 16, 1885-1890.
83. Suzuki, C., Murakami, G., Fukuchi, M., Shimanuki, T., Shikauchi, Y., Imamura, T. and Miyazono, K. (2002). Smurf1 regulates the inhibitory activity of Smad7 by targeting Smad7 to the plasma membrane. J. Biol. Chem. 277, 39919-39925.
84. Takase, M., Imamura, T., Sampath, T. K., Takeda, K., Ichijo, H., Miyazono, K. and Kawabata, M. (1998). Induction of Smad6 mRNA by bone morphogenetic proteins. Biochem. Biophys. Res. Commun. 244, 26-29.
85. Tang, H. and Goldman, D. (2006). Activity-dependent gene regulation in skeletal muscle is mediated by a histone deacetylase (HDAC)-Dach2-myogenin signal transduction cascade. Proc. Natl. Acad. Sci. USA 103, 16977-16982.
86. Timmermann, S., Lehrmann, H., Polesskaya, A. and Harel-Bellan, A. (2001). Histone acetylation and disease. Cell. Mol. Life Sci. 58, 728-736.
87. Topper, J. N., Cai, J., Qiu, Y., Anderson, K. R., Xu, Y. Y., Deeds, J. D., Feeley, R., Gimeno, C. J., Woolf, E. A., Tayber, O. et al. (1997). Vascular MADs: two novel MAD-related genes selectively inducible by flow in human vascular endothelium. Proc. Natl. Acad. Sci. USA 94, 9314-9319.
88. Trimarchi, J. M. and Lees, J. A. (2002). Sibling rivalry in the E2F family. Nat. Rev. Mol. Cell Biol. 3, 11-20.
89. Ulloa, L., Doody, J. and Massague, J. (1999). Inhibition of transforming growth factorbeta/SMAD signalling by the interferon-gamma/STAT pathway. Nature 397, 710-713.
90. Vervoorts, J., Luscher-Firzlaff, J. M., Rottmann, S., Lilischkis, R., Walsemann, G., Dohmann, K., Austen, M. and Luscher, B. (2003). Stimulation of c-MYC transcriptional activity and acetylation by recruitment of the cofactor CBP. EMBO Rep. 4, 484-490.
91. Wilting, R. H., Yanover, E., Heideman, M. R., Jacobs, H., Horner, J., van der Torre, J., DePinho, R. A. and Dannenberg, J. H. (2010). Overlapping functions of Hdac1 and Hdac2 in cell cycle regulation and haematopoiesis. EMBO J. 29, 2586-2597.
92. Wrana, J. L., Attisano, L., Wieser, R., Ventura, F. and Massague, J. (1994). Mechanism of activation of the TGF-beta receptor. Nature 370, 341-347.
93. Wu, J. W., Hu, M., Chai, J., Seoane, J., Huse, M., Li, C., Rigotti, D. J., Kyin, S., Muir, T. W., Fairman, R. et al. (2001). Crystal structure of a phosphorylated Smad2. Recognition of phosphoserine by the MH2 domain and insights on Smad function in TGF-beta signaling. Mol. Cell 8, 1277-1289.
94. Wu, M. Y. and Hill, C. S. (2009). Tgf-beta superfamily signaling in embryonic development and homeostasis. Dev. Cell 16, 329-343.
95. Yamaguchi, T., Cubizolles, F., Zhang, Y., Reichert, N., Kohler, H., Seiser, C. and Matthias, P. (2010). Histone deacetylases 1 and 2 act in concert to promote the G1-to-S progression. Genes Dev. 24, 455-469.
96. Yang, X. J. and Seto, E. (2007). HATs and HDACs: from structure, function and regulation to novel strategies for therapy and prevention. Oncogene 26, 5310-5318.
97. Yang, X. J. and Seto, E. (2008). Lysine acetylation: codified crosstalk with other posttranslational modifications. Mol. Cell 31, 449-461.
98. Yingling, J. M., Das, P., Savage, C., Zhang, M., Padgett, R. W. and Wang, X. F. (1996). Mammalian dwarfins are phosphorylated in response to transforming growth factor beta and are implicated in control of cell growth. Proc. Natl. Acad. Sci. USA 93, 8940-8944.
99. Yoshikawa, S. I., Aota, S., Shirayoshi, Y. and Okazaki, K. (2000). The ActR-I activin receptor protein is expressed in notochord, lens placode and pituitary primordium cells in the mouse embryo. Mech. Dev. 91, 439-444.
100. Zhang, H. S., Gavin, M., Dahiya, A., Postigo, A. A., Ma, D., Luo, R. X., Harbour, J. W. and Dean, D. C. (2000). Exit from G1 and S phase of the cell cycle is regulated by repressor complexes containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF. Cell 101, 79-89.
101. Zhang, Y., Feng, X., We, R. and Derynck, R. (1996). Receptor-associated Mad homologues synergize as effectors of the TGF-beta response. Nature 383, 168-172.
102. Zhong, H., May, M. J., Jimi, E. and Ghosh, S. (2002). The phosphorylation status of nuclear NF-kappa B determines its association with CBP/p300 or HDAC-1. Mol. Cell 9, 625-636.